Citations (43)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Peng-fei Tang, Xiang Zheng, Xiao-xia Hu, Cheng-cheng Yang, Zhe Chen, Jian-chang Qian, Jian-ping Cai & Guo-xin Hu. (2020) Functional Measurement of CYP2C9 and CYP3A4 Allelic Polymorphism on Sildenafil Metabolism. Drug Design, Development and Therapy 14, pages 5129-5141.
Read now
Read now
Dongxu Wang, Da-Peng Dai, Hualan Wu, Jia Chong, You Lü, Ruoyun Yin, Xinlong Zhao, Anxu Zhao, Jiefu Yang & Hao Chen. (2020) Effects of Rare CYP2C9 Alleles on Stable Warfarin Doses in Chinese Han Patients with Atrial Fibrillation. Pharmacogenomics 21:14, pages 1021-1031.
Read now
Read now
Takeshi Hirota & Ichiro Ieiri. (2015) Drug–drug interactions that interfere with statin metabolism. Expert Opinion on Drug Metabolism & Toxicology 11:9, pages 1435-1447.
Read now
Read now
Li Wang, Shi-Hui Bao, Pei-Pei Pan, Meng-Ming Xia, Meng-Chun Chen, Bing-Qing Liang, Da-Peng Dai, Jian-Ping Cai & Guo-Xin Hu. (2015) Effect of CYP2C9 genetic polymorphism on the metabolism of flurbiprofen in vitro. Drug Development and Industrial Pharmacy 41:8, pages 1363-1367.
Read now
Read now
Z. Li, G. Wang, L.-S. Wang, W. Zhang, Z.-R. Tan, L. Fan, B.-L. Chen, Q. Li, J. Liu, J.-H. Tu, D.-L. Hu, Z.-Q. Liu & H.-H. Zhou. (2009) Effects of the CYP2C9*13 allele on the pharmacokinetics of losartan in healthy male subjects. Xenobiotica 39:10, pages 788-793.
Read now
Read now
Shu-Feng Zhou, Jun-Ping Liu & Balram Chowbay. (2009) Polymorphism of human cytochrome P450 enzymes and its clinical impact. Drug Metabolism Reviews 41:2, pages 89-295.
Read now
Read now
James J Cali, Dongping Ma, Mary Sobol, Daniel J Simpson, Susan Frackman, Troy D Good, William J Daily & David Liu. (2006) Luminogenic cytochrome P450 assays. Expert Opinion on Drug Metabolism & Toxicology 2:4, pages 629-645.
Read now
Read now
Articles from other publishers (36)
Ling-jing Yuan, Xiang-yu Li, Feng Ye, Xin-yue Li, Qing-qing Li, Yun-shan Zhong, Shi-yu Wang, Ya-hui Wang, Guo-xin Hu, Jian-ping Cai & Jun-wei Li. (2023) Enzymatic activity of 38 CYP2C9 genotypes on ibuprofen. Food and Chemical Toxicology 178, pages 113926.
Crossref
Crossref
Alexey V. Kuzikov, Tatiana A. Filippova, Rami A. Masamrekh & Victoria V. Shumyantseva. (2022) Electroanalysis of 4′-Hydroxydiclofenac for CYP2C9 Enzymatic Assay. Electrocatalysis 13:5, pages 630-640.
Crossref
Crossref
Victoria V. Shumyantseva, Tatiana V. Bulko, Polina I. Koroleva, Evgeniya V. Shikh, Anna A. Makhova, Maryia S. Kisel, Irina V. Haidukevich & Andrei A. Gilep. (2022) Human Cytochrome P450 2C9 and Its Polymorphic Modifications: Electroanalysis, Catalytic Properties, and Approaches to the Regulation of Enzymatic Activity. Processes 10:2, pages 383.
Crossref
Crossref
Nam-Tae Kim, Chang‑Keun Cho, Pureum Kang, Hye-Jung Park, Yun Jeong Lee, Jung‑Woo Bae, Choon-Gon Jang & Seok-Yong Lee. (2021) Effects of CYP2C9*3 and *13 alleles on the pharmacokinetics and pharmacodynamics of glipizide in healthy Korean subjects. Archives of Pharmacal Research 45:2, pages 114-121.
Crossref
Crossref
Manish Manish, Andrew M Lynn & Smriti Mishra. (2020) Cytochrome P450 2C9 polymorphism: Effect of amino acid substitutions on protein flexibility in the presence of tamoxifen. Computational Biology and Chemistry 84, pages 107166.
Crossref
Crossref
Myung-A Cho, Jihoon G. Yoon, Vitchan Kim, Harim Kim, Rowoon Lee, Min Goo Lee & Donghak Kim. (2019) Functional Characterization of Pharmcogenetic Variants of Human Cytochrome P450 2C9 in Korean Populations. Biomolecules & Therapeutics 27:6, pages 577-583.
Crossref
Crossref
Lauren B. Arendse & Jonathan M. Blackburn. (2018) Effects of polymorphic variation on the thermostability of heterogenous populations of CYP3A4 and CYP2C9 enzymes in solution. Scientific Reports 8:1.
Crossref
Crossref
Fayou Yang, Xiaomin Xiong, Yonghua Liu, Hong Zhang, Shibo Huang, Yuqing Xiong, Xiao Hu & Chunhua Xia. (2018) CYP2C9 and OATP1B1 genetic polymorphisms affect the metabolism and transport of glimepiride and gliclazide. Scientific Reports 8:1.
Crossref
Crossref
Se-Hyung Kim, Do-Hoon Kim, Ji-Yeong Byeon, Young-Hoon Kim, Dong-Hyun Kim, Hye-Jin Lim, Choong-Min Lee, Sang Sup Whang, Chang-Ik Choi, Jung-Woo Bae, Yun Jeong Lee, Choon-Gon Jang & Seok-Yong Lee. (2016) Effects of CYP2C9 genetic polymorphisms on the pharmacokinetics of celecoxib and its carboxylic acid metabolite. Archives of Pharmacal Research 40:3, pages 382-390.
Crossref
Crossref
Hyun-Jee Lee, Young-Hoon Kim, Se-Hyung Kim, Choong-Min Lee, Ae-Yun Yang, Choon-Gon Jang, Seok-Yong Lee, Jung-Woo Bae & Chang-Ik Choi. (2016) Effects of CYP2C9 genetic polymorphisms on the pharmacokinetics of zafirlukast. Archives of Pharmacal Research 39:7, pages 1013-1019.
Crossref
Crossref
Huihui Du, Zhiyun Wei, Yucai Yan, Yuyu Xiong, Xiaoqing Zhang, Lu Shen, Yunfeng Ruan, Xi Wu, Qingqing Xu, Lin He & Shengying Qin. (2016) Functional Characterization of Human CYP2C9 Allelic Variants in COS-7 Cells. Frontiers in Pharmacology 7.
Crossref
Crossref
Masahiro Hiratsuka. (2016) Genetic Polymorphisms and <i>in Vitro</i> Functional Characterization of CYP2C8, CYP2C9, and CYP2C19 Allelic Variants. Biological & Pharmaceutical Bulletin Biological and Pharmaceutical Bulletin 39:11, pages 1748-1759.
Crossref
Crossref
Guo-Xin Hu, Pei-Pei Pan, Zeng-Shou Wang, Li-Ping Yang, Da-Peng Dai, Shuang-Hu Wang, Guang-Hui Zhu, Xiang-Jun Qiu, Tao Xu, Jun Luo, Qing-Quan Lian, Ren-Shan Ge & Jian-Ping Cai. (2015) In Vitro and In Vivo Characterization of 13 CYP2C9 Allelic Variants Found in Chinese Han Population. Drug Metabolism and Disposition 43:4, pages 561-569.
Crossref
Crossref
Qing-Quan Lian, Pei-Pei Pan, Jun-Wei Li, Han Lin, Guo-Xin Hu, Ming-Zhang Zuo & Jian-Ping Cai. (2015) Impact of CYP2C9 Polymorphism Found in the Chinese Population on the Metabolism of Propofol <i>in Vitro</i>. Biological & Pharmaceutical Bulletin Biological and Pharmaceutical Bulletin 38:4, pages 531-535.
Crossref
Crossref
Mengchun Chen, Youting Zhang, Peipei Pan, Li Wang, Yunyun Zhan, Hui Jin, Mengmin Xia, Xianqin Wang, Dapeng Dai, Jianping Cai & Guoxin Hu. (2014) Effects of Cytochrome P450 2C9 Polymorphism on Bosentan Metabolism. Drug Metabolism and Disposition 42:11, pages 1820-1825.
Crossref
Crossref
Y Niinuma, T Saito, M Takahashi, C Tsukada, Mi Ito, N Hirasawa & M Hiratsuka. (2013) Functional characterization of 32 CYP2C9 allelic variants. The Pharmacogenomics Journal 14:2, pages 107-114.
Crossref
Crossref
D-P Dai, R-A Xu, L-M Hu, S-H Wang, P-W Geng, J-F Yang, L-P Yang, J-C Qian, Z-S Wang, G-H Zhu, X-H Zhang, R-S Ge, G-X Hu & J-P Cai. (2013) CYP2C9 polymorphism analysis in Han Chinese populations: building the largest allele frequency database. The Pharmacogenomics Journal 14:1, pages 85-92.
Crossref
Crossref
Yasuhiro Mie, Emi Tateyama & Yasuo Komatsu. (2014) p-Aminothiophenol modification on gold surface improves stability for electrochemically driven cytochrome P450 microsome activity. Electrochimica Acta 115, pages 364-369.
Crossref
Crossref
Da-peng Dai, Yu-han Wang, Shuang-hu Wang, Pei-wu Geng, Li-ming Hu, Guo-xin Hu & Jian-ping Cai. (2013) In vitro functional characterization of 37 CYP2C9 allelic isoforms found in Chinese Han population. Acta Pharmacologica Sinica 34:11, pages 1449-1456.
Crossref
Crossref
Dayong Si, Juan Wang, Yifan Zhang, Dafang Zhong & Hui Zhou. (2012)
Distribution of
CYP2C9*13
allele in the Chinese Han and the long‐range haplotype containing
CYP2C9*13
and
CYP2C19*2
. Biopharmaceutics & Drug Disposition 33:6, pages 342-345.
Crossref
Crossref
Jed Zaretzki, Patrik Rydberg, Charles Bergeron, Kristin P. Bennett, Lars Olsen & Curt M. Breneman. (2012) RS-Predictor Models Augmented with SMARTCyp Reactivities: Robust Metabolic Regioselectivity Predictions for Nine CYP Isozymes. Journal of Chemical Information and Modeling 52:6, pages 1637-1659.
Crossref
Crossref
Chang-Ik Choi, Mi-Jeong Kim, Eun-Kyung Chung, Hye-In Lee, Choon-Gon Jang, Jung-Woo Bae & Seok-Yong Lee. (2011) CYP2C9*3 and *13 alleles significantly affect the pharmacokinetics of irbesartan in healthy Korean subjects. European Journal of Clinical Pharmacology 68:2, pages 149-154.
Crossref
Crossref
Masahiro Hiratsuka. (2012) In Vitro Assessment of the Allelic Variants of Cytochrome P450. Drug Metabolism and Pharmacokinetics 27:1, pages 68-84.
Crossref
Crossref
Im-Soon Lee & Donghak Kim. (2011) Polymorphic metabolism by functional alterations of human cytochrome P450 enzymes. Archives of Pharmacal Research 34:11, pages 1799-1816.
Crossref
Crossref
Hong‐Guang Xie. 2011. Molecular Microbiology. Molecular Microbiology
803
832
.
Jung‐Woo Bae, Chang‐Ik Choi, Choon‐Gon Jang & Seok‐Yong Lee. (2011)
Effects of
CYP2C9
*
1/
*
13
on the pharmacokinetics and pharmacodynamics of meloxicam
. British Journal of Clinical Pharmacology 71:4, pages 550-555.
Crossref
Crossref
Shu-Feng Zhou, Zhi-Wei Zhou & Min Huang. (2010) Polymorphisms of human cytochrome P450 2C9 and the functional relevance. Toxicology 278:2, pages 165-188.
Crossref
Crossref
Davide Seripa, Andrea Pilotto, Francesco Panza, Maria Giovanna Matera & Alberto Pilotto. (2010) Pharmacogenetics of cytochrome P450 (CYP) in the elderly. Ageing Research Reviews 9:4, pages 457-474.
Crossref
Crossref
Jing Zi, Duan Liu, Pingping Ma, He Huang, Juanli Zhu, Dongqing Wei, Jin Yang & Chao Chen. (2010) Effects of CYP2C9*3 and CYP2C9* 13 on Diclofenac Metabolism and Inhibition-based Drug-Drug Interactions. Drug Metabolism and Pharmacokinetics 25:4, pages 343-350.
Crossref
Crossref
Yuranat Saikatikorn, Panida Lertkiatmongkol, Anunchai Assawamakin, Marasri Ruengjitchatchawalya & Sissades Tongsima. 2010. Computational Systems-Biology and Bioinformatics. Computational Systems-Biology and Bioinformatics
26
35
.
Keiko Maekawa, Noriko Harakawa, Emiko Sugiyama, Masahiro Tohkin, Su-Ryang Kim, Nahoko Kaniwa, Noriko Katori, Ryuichi Hasegawa, Kazuki Yasuda, Kei Kamide, Toshiyuki Miyata, Yoshiro Saito & Jun-ichi Sawada. (2009) Substrate-Dependent Functional Alterations of Seven CYP2C9 Variants Found in Japanese Subjects. Drug Metabolism and Disposition 37:9, pages 1895-1903.
Crossref
Crossref
Makiko Kusama, Kazuya Maeda, Koji Chiba, Akinori Aoyama & Yuichi Sugiyama. (2008) Prediction of the Effects of Genetic Polymorphism on the Pharmacokinetics of CYP2C9 Substrates from In Vitro Data. Pharmaceutical Research 26:4, pages 822-835.
Crossref
Crossref
Dayong Si, Ying Wang, Yi-Han Zhou, Yingjie Guo, Juan Wang, Hui Zhou, Ze-Sheng Li & J. Paul Fawcett. (2009) Mechanism of CYP2C9 Inhibition by Flavones and Flavonols. Drug Metabolism and Disposition 37:3, pages 629-634.
Crossref
Crossref
Giovanna D?Andrea, Rosa D?Ambrosio & Maurizio Margaglione. (2008) Oral anticoagulants: Pharmacogenetics. Blood Reviews 22:3, pages 127-140.
Crossref
Crossref
Yifan Zhang, Dayong Si, Xiaoyan Chen, Nan Lin, Yingjie Guo, Hui Zhou & Dafang Zhong. (2007) Influence of CYP2C9 and CYP2C19 genetic polymorphisms on pharmacokinetics of gliclazide MR in Chinese subjects. British Journal of Clinical Pharmacology 64:1, pages 67-74.
Crossref
Crossref
Y.-H. Zhou, Q.-C. Zheng, Z.-S. Li, Y. Zhang, M. Sun, C.-C. Sun, D. Si, L. Cai, Y. Guo & H. Zhou. (2006) On the human CYP2C9*13 variant activity reduction: a molecular dynamics simulation and docking study. Biochimie 88:10, pages 1457-1465.
Crossref
Crossref